250 ML lidocaine hydrochloride 8 MG/ML Injection

RxCUI: 1737723
RxNorm name: 250 ML lidocaine hydrochloride 8 MG/ML Injection
Display name: Lidocaine (Injectable)
Full name: 250 ML lidocaine hydrochloride 8 MG/ML Injection
Term type: SCD
Status: Active
Strength: 8 mg/ml
Dose form: Injection 250 ml
Route: Injectable
Updated: 2026-10-21 07:30:30

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 032016
Active start: 032016
Multiple ingredient: NO
Branded: NO

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
lidocaine hydrochloride	8 MG / 1 ML	lidocaine	lidocaine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Injection	1649574

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
lidocaine	6387

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	250 ML lidocaine hydrochloride 8 MG/ML Injection	1	NAMES
RxNorm Name	250 ML lidocaine hydrochloride 8 MG/ML Injection	1	NAMES
RxNorm Synonym	2 linked values lidocaine HCl 0.8 % per 250 ML Injection lidocaine HCl 2 GM per 250 ML Injection	2	NAMES
TTY	SCD	1	ATTRIBUTES
SPL_SET_ID	3 linked values 1bf999b5-e290-dcbd-e063-6294a90a2bab 7dff29d9-522d-40eb-a9d9-42377912d640 f21512ea-c7c3-4766-b976-b2c0b5616bf0	3	CODES
RxCUI	1737723	1	CODES
MMSL_CODE	BD1804	1	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
0264-9598-20	0264-9598	Lidocaine Hydrochloride and Dextrose LIDOCAINE HYDROCHLORIDE ANHYDROUS and DEXTROSE MONOHYDRATE	B. Braun Medical Inc.	NDA019830
0338-0411-02	0338-0411	Lidocaine Hydrochloride and Dextrose Lidocaine Hydrochloride	Baxter Healthcare Corporation	NDA018461
51662-1657-1	51662-1657	LIDOCAINE HYDROCHLORIDE AND DEXTROSE LIDOCAINE HYDROCHLORIDE AND DEXTROSE	HF Acquisition Co LLC, DBA HealthFirst	NDA018461

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
NDA019830	0264-9598	Lidocaine Hydrochloride and Dextrose LIDOCAINE HYDROCHLORIDE ANHYDROUS and DEXTROSE MONOHYDRATE	NDA	B. Braun Medical Inc.
NDA018461	0338-0411	Lidocaine Hydrochloride and Dextrose Lidocaine Hydrochloride	NDA	Baxter Healthcare Corporation

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 11 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
00264959820	rxnav_ndcs	yes
00338041102	rxnav_ndcs	yes
50090455500	rxnav_ndcs	yes
51662165701	rxnav_ndcs	yes
00074154002	rxnav_historical_indirect
00074793932	rxnav_historical_indirect
00264559810	rxnav_historical_indirect
00264959810	rxnav_historical_indirect
00338041103	rxnav_historical_indirect
00409793932	rxnav_historical_indirect
51662156501	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lidocaine Hydrochloride and Dextrose	LIDOCAINE HYDROCHLORIDE	Baxter Healthcare Corporation	f21512ea-c7c3-4766-b976-b2c0b5616bf0	2026-02-20	Warnings, Adverse reactions	Exact identifier ndc (package): 0338-0411-02 ndc (product): 0338-0411 ndc11 (package): 00338041102 rxcui: 1737723
LIDOCAINE HYDROCHLORIDE AND DEXTROSE	LIDOCAINE HYDROCHLORIDE AND DEXTROSE	HF Acquisition Co LLC, DBA HealthFirst	1bf999b5-e290-dcbd-e063-6294a90a2bab	2026-01-20	Warnings, Adverse reactions	Exact identifier ndc (package): 51662-1657-1 ndc (product): 51662-1657 ndc11 (package): 51662165701 rxcui: 1737723
Lidocaine Hydrochloride and Dextrose	LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE	B. Braun Medical Inc.	7dff29d9-522d-40eb-a9d9-42377912d640	2026-01-14	Warnings, Adverse reactions	Exact identifier ndc (package): 0264-9598-20 ndc (product): 0264-9598 ndc11 (package): 00264959820 rxcui: 1737723

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 5 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
7dff29d9-522d-40eb-a9d9-42377912d640	lidocaine HCl 0.8 % in 250 ML Injection [PSN] · 250 ML lidocaine hydrochloride 8 MG/ML Injection [SCD] · lidocaine HCl 0.8 % per 250 ML Injection [SY] · lidocaine HCl 2 GM per 250 ML Injection [SY]	4	19	Lidocaine Hydrochloride and 5% Dextrose Injection USP	20260114
f21512ea-c7c3-4766-b976-b2c0b5616bf0	lidocaine HCl 0.8 % in 250 ML Injection [PSN] · 250 ML lidocaine hydrochloride 8 MG/ML Injection [SCD] · lidocaine HCl 0.8 % per 250 ML Injection [SY] · lidocaine HCl 2 GM per 250 ML Injection [SY]	4	17	Lidocaine Hydrochloride and 5% Dextrose Injection, USP in Plastic Container Viaflex Plus Container	20260220
564e6d42-0d74-40bd-b989-81ff67d7241c	lidocaine HCl 0.8 % in 250 ML Injection [PSN] · 250 ML lidocaine hydrochloride 8 MG/ML Injection [SCD] · lidocaine HCl 0.8 % per 250 ML Injection [SY] · lidocaine HCl 2 GM per 250 ML Injection [SY]	4	4	Lidocaine Hydrochloride and 5% Dextrose Injection USP	20191007
1bf999b5-e290-dcbd-e063-6294a90a2bab	lidocaine HCl 0.8 % in 250 ML Injection [PSN] · 250 ML lidocaine hydrochloride 8 MG/ML Injection [SCD] · lidocaine HCl 0.8 % per 250 ML Injection [SY] · lidocaine HCl 2 GM per 250 ML Injection [SY]	4	2		20260120
c75311e3-ca6e-40de-e053-2a95a90a1bda	lidocaine HCl 0.8 % in 250 ML Injection [PSN] · 250 ML lidocaine hydrochloride 8 MG/ML Injection [SCD] · lidocaine HCl 0.8 % per 250 ML Injection [SY] · lidocaine HCl 2 GM per 250 ML Injection [SY]	4	1	LIDOCAINE HCI AND 5% DEXTROSE INJECTION USP, 2g (8mg/mL)	20210717

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
f21512ea-c7c3-4766-b976-b2c0b5616bf0	Lidocaine Hydrochloride and 5% Dextrose Injection, USP in Plastic Container Viaflex Plus Container	Baxter Healthcare Corporation	20260220
1bf999b5-e290-dcbd-e063-6294a90a2bab		HF Acquisition Co LLC, DBA HealthFirst	20260120
7dff29d9-522d-40eb-a9d9-42377912d640	Lidocaine Hydrochloride and 5% Dextrose Injection USP	B. Braun Medical Inc.	20260114
c75311e3-ca6e-40de-e053-2a95a90a1bda	LIDOCAINE HCI AND 5% DEXTROSE INJECTION USP, 2g (8mg/mL)	HF Acquisition Co LLC, DBA HealthFirst	20210717
564e6d42-0d74-40bd-b989-81ff67d7241c	Lidocaine Hydrochloride and 5% Dextrose Injection USP	A-S Medication Solutions	20191007
147ce66e-0f94-4bf7-9f2f-f1fe6707bcd6		National Council for Prescription Drug Programs	20120724
8df11d4e-cd74-448b-9c7b-65ec4e85c149		National Council for Prescription Drug Programs	20120724
b771e8c0-33bb-4032-9dc2-76b1924ae4c6		National Council for Prescription Drug Programs	20120724

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	N01BB	Amides	ATC1-4		lidocaine
ATC	S02DA	Analgesics and anesthetics	ATC1-4		lidocaine
ATC	D04AB	Anesthetics for topical use	ATC1-4		lidocaine
ATC	R02AD	Anesthetics, local	ATC1-4		lidocaine
ATC	C01BB	Antiarrhythmics, class Ib	ATC1-4		lidocaine
ATC	S01HA	Local anesthetics	ATC1-4		lidocaine
ATC	C05AD	Local anesthetics	ATC1-4		lidocaine
FDASPL	N0000175682	Amide Local Anesthetic	EPC	has_epc	lidocaine
FDASPL	N0000175426	Antiarrhythmic	EPC	has_epc	lidocaine
FDASPL	N0000175976	Local Anesthesia	PE	has_pe	lidocaine
MEDRT	D008012	Lidocaine	CHEM	has_ingredient	lidocaine hydrochloride
MEDRT	D008012	Lidocaine	CHEM	has_ingredient	lidocaine
MEDRT	D000219	Adams-Stokes Syndrome	DISEASE	ci_with	lidocaine hydrochloride
MEDRT	D000219	Adams-Stokes Syndrome	DISEASE	ci_with	lidocaine
MEDRT	D002056	Burns	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D002056	Burns	DISEASE	may_treat	lidocaine
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	lidocaine hydrochloride
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	lidocaine
MEDRT	D064420	Drug-Related Side Effects and Adverse Reactions	DISEASE	may_treat	lidocaine
MEDRT	D064420	Drug-Related Side Effects and Adverse Reactions	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D004935	Esophageal Diseases	DISEASE	may_treat	lidocaine
MEDRT	D004935	Esophageal Diseases	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D006967	Hypersensitivity	DISEASE	ci_with	lidocaine hydrochloride
MEDRT	D006967	Hypersensitivity	DISEASE	ci_with	lidocaine
MEDRT	D009059	Mouth Diseases	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D009059	Mouth Diseases	DISEASE	may_treat	lidocaine
MEDRT	D009203	Myocardial Infarction	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D010146	Pain	DISEASE	may_prevent	lidocaine hydrochloride
MEDRT	D010146	Pain	DISEASE	may_prevent	lidocaine
MEDRT	D010146	Pain	DISEASE	may_treat	lidocaine
MEDRT	D010146	Pain	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D013614	Tachycardia, Paroxysmal	DISEASE	may_treat	lidocaine
MEDRT	D013614	Tachycardia, Paroxysmal	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D017180	Tachycardia, Ventricular	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D017180	Tachycardia, Ventricular	DISEASE	may_treat	lidocaine
MEDRT	D018754	Ventricular Dysfunction	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D014693	Ventricular Fibrillation	DISEASE	may_treat	lidocaine
MEDRT	D014693	Ventricular Fibrillation	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	D018879	Ventricular Premature Complexes	DISEASE	may_treat	lidocaine
MEDRT	D018879	Ventricular Premature Complexes	DISEASE	may_treat	lidocaine hydrochloride
MEDRT	N0000000180	Sodium Channel Interactions	MOA	has_moa	lidocaine
MEDRT	N0000000180	Sodium Channel Interactions	MOA	has_moa	lidocaine hydrochloride
MEDRT	N0000008330	Cardiac Rhythm Alteration	PE	has_pe	lidocaine
MEDRT	N0000008330	Cardiac Rhythm Alteration	PE	has_pe	lidocaine hydrochloride
MEDRT	N0000008472	Decreased Cardiac Muscle Organized Electrical Activity	PE	has_pe	lidocaine
MEDRT	N0000008472	Decreased Cardiac Muscle Organized Electrical Activity	PE	has_pe	lidocaine hydrochloride
MEDRT	N0000008889	Decreased Sensory-Somatic Nervous System Organized Electrical Activity	PE	has_pe	lidocaine
MEDRT	N0000008889	Decreased Sensory-Somatic Nervous System Organized Electrical Activity	PE	has_pe	lidocaine hydrochloride
MEDRT	N0000175976	Local Anesthesia	PE	has_pe	lidocaine
MEDRT	N0000175976	Local Anesthesia	PE	has_pe	lidocaine hydrochloride

Group, Type, Concept table
Group	Type	Concept	Source
DF	DF	Injection	rxnav_allrelated
DFG	DFG	Injectable Product	rxnav_allrelated
IN	IN	lidocaine	rxnav_allrelated
PIN	PIN	lidocaine hydrochloride	rxnav_allrelated
SCD	SCD	250 ML lidocaine hydrochloride 8 MG/ML Injection	rxnav_allrelated
SCDC	SCDC	lidocaine hydrochloride 8 MG/ML	rxnav_allrelated
SCDF	SCDF	lidocaine Injection	rxnav_allrelated
SCDFP	SCDFP	lidocaine hydrochloride Injection	rxnav_allrelated
SCDG	SCDG	lidocaine Injectable Product	rxnav_allrelated
SCDGP	SCDGP	lidocaine hydrochloride Injectable Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	8 MG/ML
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	QUANTITY	250 ML
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
CODES	NDA	NDA018461
CODES	NDA	NDA019830
CODES	VUID	4005951
NAMES	Prescribable Synonym	lidocaine HCl 0.8 % in 250 ML Injection
SOURCES	Source	Gold Standard Alchemy
SOURCES	Source	Metathesaurus FDA Structured Product Labels
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	Multum MediSource Lexicon
SOURCES	Source	National Drug Data File Plus Source Vocabulary
SOURCES	Source	Veterans Health Administration National Drug File